Predictors of treatment choice in patients with COPD

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/10178
• EU PAS number:
  EUPAS10165
• Study ID:
  10178
• Official title and acronym:
  Predictors of treatment choice in patients with COPD
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  A retrospective observational cohort study that investigates predictors of initial treatment choice in COPD patients.
• Study status:
  Planned

Research institution and networks

Institutions

Research in Real Life

Study timelines

Date when funding contract was signed

Planned: 03/02/2014

Study start date

Planned: 17/02/2014

Date of final study report

Planned: 01/09/2015

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Novartis Pharmaceuticals

Study protocol

Initial protocol

Encepp protocol_Prescription Patterns Manuscript

Updated protocol

Predictors of treatment choice in patients with COPD_ENCePP protocol

Regulatory

• Was the study required by a regulatory body?:
  No